# DESCRIPTION

## STATEMENT AS TO RIGHTS TO INVENTIONS MADE UNDER FEDERALLY SPONSORED RESEARCH AND DEVELOPMENT

- acknowledge government support

## BACKGROUND OF THE INVENTION

- propose origins of primordial germ cells
- discuss limitations of previous studies
- summarize controversies in germ cell development
- highlight need for robust in vitro platform
- introduce solution to problems in the art

## BRIEF SUMMARY OF THE INVENTION

- provide method for forming primordial germ cell
- describe method for isolating primordial germ cell
- outline method for forming primordial germ cell
- detail method for isolating primordial germ cell
- provide method for treating infertility
- describe various aspects of primordial germ cells

## DETAILED DESCRIPTION OF THE INVENTION

- introduce compositions and methods

### Definitions

- introduce patent application
- define scope of invention
- explain section headings
- incorporate references by reference
- define singular and plural articles
- define open-ended terms
- define "about"
- define "nucleic acid"
- define "polynucleotide"
- describe nucleic acid structure
- define "duplex"
- describe branched nucleic acids
- define nucleic acid analogues
- define nucleic acid mimetics
- define "nucleic acid" synonyms
- describe polynucleotide functions
- define "polynucleotide sequence"
- describe non-standard nucleotides
- define "reactive moiety"
- describe nucleic acid modifications
- define "labeled nucleic acid"
- define "detectable label"
- describe label conjugation methods
- define "nonspecific sequence"
- describe scrambled sequences
- define "complementary"
- define "perfectly complementary"
- define "substantially complementary"
- describe stringent hybridization conditions
- describe moderately stringent hybridization conditions
- define "gene"
- define "protein gene product"
- define "expression"
- define "transcriptional regulatory sequence"
- define transcription start site
- define promoter
- define enhancer
- define silencer
- define amino acid
- define polypeptide, peptide, and protein
- define fusion protein
- define conservatively modified variants
- describe percentage of sequence identity
- define identical or percent identity
- define amino acid or nucleotide base position
- define numbered with reference to
- describe specific proteins (e.g., TGFβ, BMP4, CXCR4, PDGFRα, SCF, EGF)
- define PDGFRα
- define CXCR4
- define BMP
- define EGF
- define Wnt protein
- define detectable agent or detectable moiety
- describe examples of detectable agents
- define recombinant
- describe recombinant cells
- describe recombinant nucleic acids
- describe recombinant proteins
- describe recombinant vectors
- describe modified amino acid residues
- describe labeled amino acid residues
- describe modified proteins
- describe labeled proteins
- describe protein modifications
- describe protein labeling
- describe protein modifications and labeling
- describe protein modifications and labeling examples
- describe protein modifications and labeling applications
- describe protein modifications and labeling methods
- describe protein modifications and labeling techniques
- describe protein modifications and labeling tools
- describe protein modifications and labeling systems
- describe protein modifications and labeling platforms
- define isolated nucleic acid or protein
- define cell
- define primordial germ cell (PGC)
- define epiblast
- define posterior epiblast
- define posterior epiblast cell
- define stem cell
- define pluripotent stem cells
- define cell culture media
- list exemplary culture media
- describe supplements for culture media
- describe serum in culture media
- describe serum-free culture media
- describe media supplements
- describe antibiotics in culture media
- describe other exemplary supplements
- describe culture medium composition
- define cell culture container
- describe cell culture container types
- describe multiwell cell culture plates
- describe cell population in cell culture container
- describe pluripotent stem cell population
- describe posterior epiblast cell population
- describe cell population comprising a PGC
- describe cell culture conditions
- describe cell culture methods
- describe applications of cell culture
- define surface coating materials
- list exemplary surface coating materials
- describe MATRIGEL
- define cell culture conditions
- describe CO2 level control
- describe temperature control
- describe O2 level control
- define vector
- describe plasmid
- describe viral vector
- describe expression vector
- define transfection and transduction
- describe non-viral transfection methods
- describe viral-based transfection methods
- define contacting
- describe inhibition
- define inhibitor
- describe agonist
- define control
- describe control sample
- describe control value
- describe significance of control
- describe use of control
- define patient
- define disease or condition
- define treatment
- explain therapeutic benefit
- explain prophylactic benefit
- define dose and dosage
- define effective amount
- define reduction
- define prophylactically effective amount
- define activity decreasing amount
- define function disrupting amount
- explain guidance for dosages
- define administering
- explain routes of administration
- define co-administer
- explain formulations for oral administration
- explain tablet forms
- explain lozenge forms
- explain pharmaceutical compositions
- explain carriers
- explain adjuvants
- explain formulations for rectal administration
- explain formulations for parenteral administration
- explain injection solutions and suspensions
- explain unit dosage form
- explain combined administration
- explain effective doses
- define pharmaceutically acceptable
- define pharmaceutically acceptable excipient
- define pharmaceutically acceptable salt
- define preparation
- explain solid dosage forms
- explain unit dosage form
- explain frozen dispersion
- explain sustained release and comfort components
- explain microspheres for slow release
- explain liposomes and nanoparticles

### Methods

- provide 2D in vitro platform for generating human PGCs
- simplify production of human PGCs for drug discovery
- simplify production of human PGCs for disease modeling
- simplify production of human PGCs for infertility treatments
- provide research tool to investigate key lineage intermediates
- provide research tool to investigate extracellular signals in PGC specification
- form PGC in vitro using WNT agonist and TGFβ agonist
- form posterior epiblast cell population
- contact posterior epiblast cell population with WNT inhibitor
- remove WNT agonist and TGFβ agonist
- form PGC
- isolate PGC using CXCR4+/PDGFRα-/GARP cell separation
- define separating
- define pluripotent stem cell population
- define posterior epiblast cell population
- describe WNT agonist and TGFβ agonist removal
- define WNT inhibitor
- describe WNT inhibitor activity
- define WNT agonist
- describe WNT agonist activity
- define TGFβ agonist
- describe TGFβ agonist activity
- provide examples of WNT agonists
- provide examples of WNT inhibitors
- provide examples of TGFβ agonists
- describe pluripotent stem cell marker expression
- describe posterior epiblast cell marker expression
- define TGFβ agonists
- define WNT inhibitors
- define Activin-A protein
- specify Activin-A concentrations
- specify Activin-A concentrations (continued)
- define CHIR99021
- specify CHIR99021 concentrations
- specify CHIR99021 concentrations (continued)
- define Y-27632
- specify Y-27632 concentrations
- specify Y-27632 concentrations (continued)
- specify TGFβ agonist embodiments
- specify WNT inhibitor embodiments
- specify Activin-A embodiments
- specify CHIR99021 embodiments
- specify Y-27632 embodiments
- specify pluripotent stem cell population contact
- specify pluripotent stem cell population contact (continued)
- specify pluripotent stem cell population contact (continued)
- specify pluripotent stem cell population contact (continued)
- specify pluripotent stem cell population contact (continued)
- specify pluripotent stem cell population contact (continued)
- specify pluripotent stem cell population contact (continued)
- specify pluripotent stem cell population contact (continued)
- specify pluripotent stem cell population contact (continued)
- specify pluripotent stem cell population contact (continued)
- specify pluripotent stem cell population contact (continued)
- specify pluripotent stem cell population contact (continued)
- specify pluripotent stem cell population contact (continued)
- specify pluripotent stem cell population contact (continued)
- specify pluripotent stem cell population contact (continued)
- specify pluripotent stem cell population contact (continued)
- specify pluripotent stem cell population contact (continued)
- specify pluripotent stem cell population contact (continued)
- define methods
- specify contacting duration
- specify PGC formation duration
- describe expanding cell populations
- specify contacting with BMP, SCF, EGF
- define BMP-4
- specify BMP-4 concentration
- specify BMP-4 concentration range
- define XAV939
- specify XAV939 concentration
- specify XAV939 concentration range
- specify XAV939 concentration range
- specify XAV939 concentration range
- specify XAV939 concentration range
- specify XAV939 concentration range
- specify XAV939 concentration range
- specify XAV939 concentration range
- specify XAV939 concentration range
- specify XAV939 concentration range
- specify XAV939 concentration range
- specify XAV939 concentration range
- specify XAV939 concentration range
- specify XAV939 concentration range
- specify XAV939 concentration range
- specify XAV939 concentration range
- specify XAV939 concentration range
- specify XAV939 concentration range
- specify XAV939 concentration range
- specify XAV939 concentration range
- specify XAV939 concentration range
- specify XAV939 concentration range
- specify XAV939 concentration range
- specify XAV939 concentration range
- specify XAV939 concentration range
- specify XAV939 concentration range
- specify XAV939 concentration range
- specify XAV939 concentration range
- define XAV939 concentration
- define SCF protein
- specify SCF concentration
- define BMP-4 protein
- specify BMP-4 variants
- define EGF protein
- specify EGF concentration
- specify EGF variants
- describe contacting methods
- specify cell culture conditions
- describe posterior epiblast cell markers
- specify posterior epiblast cell genes
- describe serum-free medium conditions
- specify pluripotent stem cell population
- specify human pluripotent stem cell population
- specify human embryonic stem cell population
- describe contacting sequence
- describe contacting simultaneity

### Cell Compositions

- provide cell culture composition
- define WNT-activated posterior epiblast cell
- describe CXCR4+/PDGFRα-/GARP¬ PGC
- specify cell culture conditions

### METHODS OF USE

- outline methods of using PGCs

### EXAMPLES

- introduce PGCs
- describe importance of PGCs
- limitations of current PGC generation methods
- introduce simplified monolayer method
- describe WNT activation for 12 hours
- describe posterior epiblast formation
- describe PGC specification
- describe pluripotency factors during transition
- describe purification of PGCs by surface markers
- introduce background on PGC origins
- describe differences between human and mouse PGC development
- describe uncertainty of human PGC specification
- describe previous methods to generate PGCs
- describe limitations of previous methods
- introduce goal of developing simplified 2D platform
- describe primed PSCs competence to generate PGCs
- describe brief differentiation into posterior epiblast
- describe temporally dynamic WNT and BMP pathways
- describe unique cell-surface markers for PGCs
- describe characterization of cells en route to PGC specification
- describe pluripotency transcription factors during process
- describe brief exposure to primitive streak-inducing signals
- describe generation of posterior epiblast cells
- describe bifurcation of posterior epiblast cells
- describe molecular description of posterior epiblast cells
- describe single-cell RNA-sequencing analysis
- describe temporally dynamic WNT signaling
- describe optimization of PGC differentiation
- describe effect of WNT inhibition on PGC formation
- describe effect of BMP activation on PGC formation
- describe development of monolayer, serum-free protocol
- describe generation of pure PGCs within 3.5 days
- describe expression of PGC markers
- describe surface-marker profile of hPSC-derived PGCs
- describe discovery of CXCR4+ PDGFRA- GARP- surface marker profile
- describe validation of surface marker profile
- describe generation of PGCs across diverse hESC and hiPSC lines
- describe efficiency of monolayer differentiation method
- introduce PGC purification strategy
- demonstrate PGC marker expression
- perform single-cell RNA sequencing
- analyze scRNAseq data
- identify PGC transcriptional signature
- investigate pluripotency marker expression
- engineer NANOG-2A-YFP reporter hESCs
- track NANOG expression during germline transition
- discuss PGC specification and lineage relationships
- discuss WNT signaling in germline specification
- discuss pluripotency factor expression
- discuss limitations of PGC formation
- introduce Materials and Methods section
- describe hPSC culture
- describe hPSC differentiation into PGCs
- describe immunostaining protocol
- describe high-throughput cell-surface marker screening
- describe flow cytometry and FACS protocol
- list activators and inhibitors of signaling pathways
- list antibodies used for immunostaining
- list antibodies used for flow cytometry
- describe LEGENDScreen experiment
- describe FACS analysis
- describe cell-surface marker staining
- describe antibody array replication
- describe cell dissociation and washing
- describe primary antibody staining
- describe cell washing and pelleting
- describe final cell suspension and filtering
- describe flow cytometry and sorting
- conclude Materials and Methods section
- describe RNA extraction and reverse transcription
- detail qPCR protocol
- outline single cell RNA-sequencing protocol
- describe single cell RNA-seq computational analysis
- filter out low-quality cells
- normalize and scale counts
- adjust for cell cycle effects
- perform PCA
- cluster cells using SNN algorithm
- visualize clusters using t-SNE plot
- identify differentially expressed genes
- identify enriched transcription factors
- identify enriched surface proteins and ligands and receptors
- generate plots using Seurat and ggplot2
- perform trajectory analysis
- describe surface marker screen of PGCs, non-PGCs and undifferentiated hPSCs
- list references
- introduce Chen et al. (2017)
- introduce Chiquoine (1954)
- introduce De Felici (2016)
- introduce Durruthy-Durruthy et al. (2014)
- introduce Ginsburg et al. (1990)
- introduce Hayashi et al. (2011)
- introduce Hoffman et al. (2013)
- introduce Irie et al. (2014)

## P EMBODIMENTS

- define PGC formation method
- define PGC isolation method
- specify duration of contacting step
- specify time frame for PGC formation
- specify expansion of pluripotent stem cell population
- specify additional factors for contacting step

### EMBODIMENTS

- define PGC formation method
- define PGC isolation method
- specify duration of contacting step
- specify time frame for PGC formation
- specify expansion of pluripotent stem cell population
- specify additional factors for contacting step
- specify cell culture conditions
- define PGC characteristics
- specify cell culture medium composition
- define method of treating infertility

